<DOC>
	<DOCNO>NCT02471131</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) common cardiac arrhythmia lifetime risk develop AF 1 4 people age 40 . Stroke remain feared complication AF increase risk 5-fold , leading cause morbidity mortality . The left atrial appendage ( LAA ) origin 90 % emboli non-valvular AF . The WATCHMANâ„¢ Left Atrial Closure Device ( WATCHMAN Device , Boston Scientific ) reduce risk stroke close LAA . During hybrid procedure AF , LAA occlusion epicardial device know difficult free risks.It thus interest study safety feasibility endocardial WATCHMAN Device implantation hybrid ablation approach .</brief_summary>
	<brief_title>WATCHMAN Implantation During Hybrid Ablation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Documented paroxysmal ( longstanding ) persistent nonvalvular atrial fibrillation , Eligible least shortterm OAC therapy , No condition would require longterm OAC therapy , suggest current standard medical practice , thus eligible stop OAC LAA seal , Calculated CHA2DS2VASc score 1 , 18 year age old , able willing provide write informed consent . Current New York Heart Association Class IV Congestive Heart Failure , Current thrombocytopenia ( &lt; 100x10E9/L ) anemia ( hemoglobin &lt; 6.2 mmol/L ) , Active infection sepsis , Resting heart rate &gt; 110 beat per minute , Cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) within last 30 day , Recent myocardial infarction ( within 3 month ) , Transient case AF ( i.e. , secondary recent cardiac surgery ( within 3 month ) ) , Planned cardioversion 30 day post implant WATCHMAN Device , Implanted mechanical valve prosthesis , History obliterate LAA , History heart transplantation , Symptomatic carotid disease ( i.e. , carotid stenosis &gt; 50 % associate ipsilateral transient visual ischemic attack evidence amaurosis fugax , ipsilateral hemispheric TIAs ipsilateral stroke within 6 month ) , Necessity use longterm OAC , Contraindication use OAC dual antiplatelet therapy , Contraindication use aspirin , Pregnancy plan pregnancy course investigation , Life expectancy le 2 year , Participation clinical study involve investigational drug device . Echocardiographic Exclusion Criteria ( assess via transthoracic echocardiography ( TTE ) TEE ) study : Left ventricular ejection fraction ( LVEF ) &lt; 30 % , Intracardiac thrombus visualize TEE within 2 day prior implant , High risk patent foramen ovale , Current atrial septal defect and/or previous atrial septal repair closure device , Significant mitral valve stenosis ( i.e. , MV 4 . 5 cm2 ) , Existing pericardial effusion &gt; 3 mm , Complex atheroma mobile plaque descend aorta and/or aortic arch , Cardiac tumor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>WATCHMAN</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Hybrid Ablation</keyword>
	<keyword>Safety</keyword>
	<keyword>Feasibility</keyword>
	<keyword>Stroke Prevention</keyword>
</DOC>